BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32942984)

  • 1. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder.
    Cameli C; Viggiano M; Rochat MJ; Maresca A; Caporali L; Fiorini C; Palombo F; Magini P; Duardo RC; Ceroni F; Scaduto MC; Posar A; Seri M; Carelli V; Visconti P; Bacchelli E; Maestrini E
    J Cell Mol Med; 2021 Mar; 25(5):2459-2470. PubMed ID: 33476483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.
    Ishizuka K; Fujita Y; Kawabata T; Kimura H; Iwayama Y; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Uno Y; Okada T; Ikeda M; Aleksic B; Mori D; Someya T; Yoshikawa T; Iwata N; Nakamura H; Yamashita T; Ozaki N
    Transl Psychiatry; 2017 Aug; 7(8):e1184. PubMed ID: 28763059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility.
    Kimura H; Fujita Y; Kawabata T; Ishizuka K; Wang C; Iwayama Y; Okahisa Y; Kushima I; Morikawa M; Uno Y; Okada T; Ikeda M; Inada T; Branko A; Mori D; Yoshikawa T; Iwata N; Nakamura H; Yamashita T; Ozaki N
    Transl Psychiatry; 2017 Aug; 7(8):e1214. PubMed ID: 28892071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare NRXN1 missense variants identified in autism interfered protein degradation and Drosophila sleeping.
    Liu Y; Shen L; Zhang Y; Zhao R; Liu C; Luo S; Chen J; Xia L; Li T; Peng Y; Xia K
    J Psychiatr Res; 2021 Nov; 143():113-122. PubMed ID: 34487988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic contribution of Nrxn1α to autism-relevant behavioral phenotypes in mice.
    Xu B; Ho Y; Fasolino M; Medina J; O'Brien WT; Lamonica JM; Nugent E; Brodkin ES; Fuccillo MV; Bucan M; Zhou Z
    PLoS Genet; 2023 Feb; 19(2):e1010659. PubMed ID: 36848371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequencing of selected chromatin remodelling genes reveals increased burden of rare missense variants in ASD patients from the Japanese population.
    Lo T; Kushima I; Aleksic B; Kato H; Nawa Y; Hayashi Y; Otgonbayar G; Kimura H; Arioka Y; Mori D; Ozaki N
    Int Rev Psychiatry; 2022 Feb; 34(2):154-167. PubMed ID: 35699097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Rare Single-Nucleotide PCDH15 Variants in Schizophrenia and Autism Spectrum Disorders.
    Ishizuka K; Kimura H; Wang C; Xing J; Kushima I; Arioka Y; Oya-Ito T; Uno Y; Okada T; Mori D; Aleksic B; Ozaki N
    PLoS One; 2016; 11(4):e0153224. PubMed ID: 27058588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal impact of patient-specific aberrant NRXN1α splicing.
    Flaherty E; Zhu S; Barretto N; Cheng E; Deans PJM; Fernando MB; Schrode N; Francoeur N; Antoine A; Alganem K; Halpern M; Deikus G; Shah H; Fitzgerald M; Ladran I; Gochman P; Rapoport J; Tsankova NM; McCullumsmith R; Hoffman GE; Sebra R; Fang G; Brennand KJ
    Nat Genet; 2019 Dec; 51(12):1679-1690. PubMed ID: 31784728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRXN1α
    Avazzadeh S; Quinlan LR; Reilly J; McDonagh K; Jalali A; Wang Y; McInerney V; Krawczyk J; Ding Y; Fitzgerald J; O'Sullivan M; Forman EB; Lynch SA; Ennis S; Feerick N; Reilly R; Li W; Shen X; Yang G; Lu Y; Peeters H; Dockery P; O'Brien T; Shen S; Gallagher L
    BMC Neurosci; 2021 Sep; 22(1):56. PubMed ID: 34525970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder.
    Kato H; Kushima I; Mori D; Yoshimi A; Aleksic B; Nawa Y; Toyama M; Furuta S; Yu Y; Ishizuka K; Kimura H; Arioka Y; Tsujimura K; Morikawa M; Okada T; Inada T; Nakatochi M; Shinjo K; Kondo Y; Kaibuchi K; Funabiki Y; Kimura R; Suzuki T; Yamakawa K; Ikeda M; Iwata N; Takahashi T; Suzuki M; Okahisa Y; Takaki M; Egawa J; Someya T; Ozaki N
    Transl Psychiatry; 2020 Dec; 10(1):421. PubMed ID: 33279929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of
    Furuta S; Aleksic B; Nawa Y; Kimura H; Kushima I; Ishizuka K; Kato H; Toyama M; Arioka Y; Mori D; Morikawa M; Inada T; Ozaki N
    Nagoya J Med Sci; 2022 May; 84(2):260-268. PubMed ID: 35967956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Ca
    Avazzadeh S; McDonagh K; Reilly J; Wang Y; Boomkamp SD; McInerney V; Krawczyk J; Fitzgerald J; Feerick N; O'Sullivan M; Jalali A; Forman EB; Lynch SA; Ennis S; Cosemans N; Peeters H; Dockery P; O'Brien T; Quinlan LR; Gallagher L; Shen S
    Mol Autism; 2019; 10():52. PubMed ID: 31893021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders.
    Hu Z; Xiao X; Zhang Z; Li M
    Mol Psychiatry; 2019 Oct; 24(10):1400-1414. PubMed ID: 31138894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic and Gene Regulatory Mechanisms in Schizophrenia, Autism, and 22q11.2 Copy Number Variant-Mediated Risk for Neuropsychiatric Disorders.
    Forsyth JK; Nachun D; Gandal MJ; Geschwind DH; Anderson AE; Coppola G; Bearden CE
    Biol Psychiatry; 2020 Jan; 87(2):150-163. PubMed ID: 31500805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ultra-rare disruptive variants in voltage-gated calcium channel-encoding genes in Japanese samples of schizophrenia and autism spectrum disorder.
    Wang C; Horigane SI; Wakamori M; Ueda S; Kawabata T; Fujii H; Kushima I; Kimura H; Ishizuka K; Nakamura Y; Iwayama Y; Ikeda M; Iwata N; Okada T; Aleksic B; Mori D; Yoshida T; Bito H; Yoshikawa T; Takemoto-Kimura S; Ozaki N
    Transl Psychiatry; 2022 Feb; 12(1):84. PubMed ID: 35220405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Saturation Mutagenesis to Investigate the Effects of Neurexin-1 Mutations on AlphaFold Structure.
    Rhoades R; Henry B; Prichett D; Fang Y; Teng S
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.